tiprankstipranks
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market

Jubilant Pharmova Limited (JUBLPHARMA) Financial Statements

Compare
1 Followers

Jubilant Pharmova Limited Financial Overview

Jubilant Pharmova Limited's market cap is currently ₹154.16B. The company's EPS TTM is ₹39.61; its P/E ratio is 24.02; and it has a dividend yield of 0.52%. Jubilant Pharmova Limited is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is ₹6.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 66.45B₹ 62.19B₹ 60.59B₹ 59.64B₹ 89.77B
Gross Profit₹ 19.06B₹ 43.41B₹ 42.72B₹ 42.10B₹ 55.22B
Operating Income₹ 5.19B₹ 3.75B₹ 8.40B₹ 11.44B₹ 12.39B
EBITDA₹ 8.09B₹ 7.58B₹ 11.68B₹ 13.93B₹ 15.52B
Net Income₹ 771.00M₹ -609.80M₹ 4.14B₹ 8.36B₹ 8.98B
Balance Sheet
Cash & Short-Term Investments₹ 9.63B₹ 11.43B₹ 9.86B₹ 6.85B₹ 14.13B
Total Assets₹ 115.48B₹ 111.57B₹ 99.91B₹ 89.18B₹ 125.22B
Total Debt₹ 36.64B₹ 36.77B₹ 31.92B₹ 28.30B₹ 48.08B
Net Debt₹ 27.10B₹ 26.63B₹ 22.12B₹ 23.32B₹ 35.83B
Total Liabilities₹ 61.27B₹ 57.65B₹ 46.74B₹ 41.77B₹ 69.18B
Stockholders' Equity₹ 54.34B₹ 53.99B₹ 53.19B₹ 47.41B₹ 56.04B
Cash Flow
Free Cash Flow₹ 736.00M₹ -1.54B₹ 2.38B₹ 12.57B₹ 9.69B
Operating Cash Flow₹ 9.71B₹ 6.61B₹ 8.38B₹ 17.84B₹ 15.43B
Investing Cash Flow₹ -6.08B₹ -5.44B₹ -3.80B₹ -7.39B₹ -3.27B
Financing Cash Flow₹ -4.33B₹ -1.57B₹ -325.99M₹ -17.09B₹ -10.50B
Currency in INR

Jubilant Pharmova Limited Earnings and Revenue History

Jubilant Pharmova Limited Debt to Assets

Jubilant Pharmova Limited Cash Flow

Jubilant Pharmova Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis